Johnson & Johnson Q2 2024 10-Q Filed
Ticker: JNJ · Form: 10-Q · Filed: 2024-07-25T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, debt
TL;DR
JNJ Q2 10-Q is in, check out their debt maturities through 2044.
AI Summary
Johnson & Johnson filed its 10-Q for the period ending June 30, 2024. The company's fiscal year ends on December 29th. Key financial data and debt instruments, including notes due in 2024, 2028, 2032, 2035, 2036, and 2044, are detailed within the filing.
Why It Matters
This filing provides investors with an update on Johnson & Johnson's financial health and debt obligations for the second quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- JOHNSON & JOHNSON (company) — Filer
- 2024-06-30 (date) — Period of Report
- 2024-07-25 (date) — Filing Date
- 0000200406 (company) — Central Index Key
- 2834 (industry_code) — Standard Industrial Classification
- NJ (location) — State of Incorporation
- 12/29 (date) — Fiscal Year End
- A5.50NotesDue2024Member (debt_instrument) — Debt Maturity
- A1.150NotesDueNovember2028Member (debt_instrument) — Debt Maturity
- A3.20NotesDueNovember2032Member (debt_instrument) — Debt Maturity
FAQ
What is Johnson & Johnson's fiscal year end date?
Johnson & Johnson's fiscal year ends on December 29th.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending June 30, 2024.
What is Johnson & Johnson's Central Index Key (CIK)?
Johnson & Johnson's Central Index Key is 0000200406.
What are some of the debt instruments mentioned in the filing?
The filing mentions debt instruments such as A5.50NotesDue2024Member, A1.150NotesDueNovember2028Member, and A3.550NotesDueNovember2044Member.
In which state is Johnson & Johnson incorporated?
Johnson & Johnson is incorporated in New Jersey (NJ).
From the Filing
0000200406-24-000075.txt : 20240725 0000200406-24-000075.hdr.sgml : 20240725 20240725160229 ACCESSION NUMBER: 0000200406-24-000075 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 99 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 241141991 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 10-Q 1 jnj-20240630.htm 10-Q jnj-20240630 0000200406 12/29 2024 Q2 FALSE xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR jnj:segment jnj:entity jnj:claimant jnj:claim jnj:cases 0000200406 2024-01-01 2024-06-30 0000200406 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000200406 jnj:A5.50NotesDue2024Member 2024-01-01 2024-06-30 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-01-01 2024-06-30 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-01-01 2024-06-30 0000200406 jnj:A1.650NotesDue2035Member 2024-01-01 2024-06-30 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-01-01 2024-06-30 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-01-01 2024-06-30 0000200406 2024-07-19 0000200406 2024-06-30 0000200406 2023-12-31 0000200406 2024-04-01 2024-06-30 0000200406 2023-04-03 2023-07-02 0000200406 2023-01-02 2023-07-02 0000200406 2024-03-31 0000200406 us-gaap:RetainedEarningsMember 2024-03-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000200406 us-gaap:CommonStockMember 2024-03-31 0000200406 us-gaap:TreasuryStockCommonMember 2024-03-31 0000200406 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000200406 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000200406 us-gaap:RetainedEarningsMember 2024-06-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000200406 us-gaap:CommonStockMember 2024-06-30 0000200406 us-gaap:TreasuryStockCommonMember 2024-06-30 0000200406 us-gaap:RetainedEarningsMember 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000200406 us-gaap:CommonStockMember 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-12-31 0000200406 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0000200406 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-06-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0000200406 2023-04-02 0000200406 us-gaap:RetainedEarningsMember 2023-04-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0000200406 us-gaap:CommonStockMember 2023-04-02 0000200406 us-gaap:TreasuryStockCommonMember 2023-04-02 0000200406 us-gaap:NoncontrollingInterestMember 2023-04-02 0000200406 us-gaap:RetainedEarningsMember 2023-04-03 2023-07-02 0000200406 us-gaap:TreasuryStockCommonMember 2023-04-03 2023-07-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-03 2023-07-02 0000200406 us-gaap:NoncontrollingInterestMember 2023-04-03 2023-07-02 0000200406 2023-07-02 0000200406 us-gaap:RetainedEarningsMember 2023-07-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0000200406 us-gaap:CommonStockMember 2023-07-02 0000200406 us-gaap:TreasuryStockCommonMember 2023-07-02 0000200406 us-gaap:NoncontrollingInterestMember 2023-07-02 0000200406 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0000200406 us-gaap:CommonStockMember 2023-01-01 0000200406 us-gaap:TreasuryStockCommo